Ixazomib y sus efectos secundarios
(3)
Ácido acético 2- (2,5-diclorobenzamido) (667403-46-5)
Precio: Negotiable
MOQ: Negotiable
El tiempo de entrega: Negotiable
Destacar:CAS: 667403-46-5 Ixazomib, Ixazomib intermediate Anti Tumor, Ixazomib intermediate 667403-46-5
2-(2,5-dichlorobenzamido)acetic acid (667403-46-5) 2-(2,5-dichlorobenzamido)acetic acid is used in the preparation of Ixazomib. Product Name: 2-(2,5-dichlorobenzamido)acetic acid CAS No.: 667403-46-5 Assay: 98% End Use: Ixazomib Molecular Formula: C9H7Cl2NO3 Molecular Weight: 248.06 Shelf Life: 2 Ye... Ver más
➤ Visitar Sitio web
(αR) - ((1S,2S,3R,5S) -Pinanediol-1-amino-3-metilbutano-1-boronato de trifluoroacetato (179324-87-9)
Precio: Negotiable
MOQ: Negotiable
El tiempo de entrega: Negotiable
Destacar:CAS 179324-87-9 Ixazomib, Ixazomib proteasome inhibitor, Ixazomib 179324-87-9
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate (179324-87-9) (aR,3aS,4S,6S,7aR)-hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate is used in the design and preparation of Ixazomib and Bortezomib... Ver más
➤ Visitar Sitio web
Citrato de ixazomib (1201902-80-8)
Precio: Negotiable
MOQ: Negotiable
El tiempo de entrega: Negotiable
Destacar:Ixazomib Citrate 1201902-80-8, Ixazomib API 1201902-80-8, Ixazomib proteasome inhibitor
Ixazomib Citrate (1201902-80-8) Ixazomib citrate is a proteasome inhibitor that acts by preventing cell growth in solid tumours. It is an anti-cancer agent that is used for treatment of multiple myeloma. Compared with bortezomib, Ixazomib citrate obtains higher pharmacokinetics, efficacy, and antica... Ver más
➤ Visitar Sitio web